Quantitative Assessment of Immunohistochemistry Laboratory Performance by Measuring Analytic Response Curves and Limits of Detection

被引:19
作者
Sompuram, Seshi R. [1 ]
Vani, Kodela [1 ]
Schaedle, Anika K. [1 ]
Balasubramanian, Anuradha [1 ]
Bogen, Steven A. [1 ,2 ]
机构
[1] Med Discovery Partners LLC, Boston, MA USA
[2] Tufts Med Ctr, Dept Pathol & Lab Med, Boston, MA USA
基金
美国国家卫生研究院;
关键词
RABBIT MONOCLONAL-ANTIBODY; PROGESTERONE-RECEPTOR ASSAYS; IN-SITU HYBRIDIZATION; CELL-LINE STANDARD; BREAST-CANCER; ESTROGEN-RECEPTOR; QUALITY-CONTROL; HER2; EXPRESSION; SP1;
D O I
10.5858/arpa.2017-0330-OA
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Numerous studies highlight interlaboratory performance variability in diagnostic immunohistochemistry (IHC) testing. Despite substantial improvements over the years, the inability to quantitatively and objectively assess immunostain sensitivity complicates interlaboratory standardization. Objective.-To quantitatively and objectively assess the sensitivity of the immunohistochemical stains for human epidermal growth factor receptor type 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR) across IHC laboratories in a proficiency testing format. We measure sensitivity with parameters that are new to the field of diagnostic IHC: analytic response curves and limits of detection. Design.-Thirty-nine diagnostic IHC laboratories stained a set of 3 slides, one each for HER2, ER, and PR. Each slide incorporated a positive tissue section and IHControls at 5 different concentrations. The IHControls comprise cell-sized clear microbeads coated with defined concentrations of analyte (HER2, ER, and/or PR). The laboratories identified the limits of detection and then mailed the slides for quantitative assessment. Results.-Each commercial immunostain demonstrated a characteristic analytic response curve, reflecting strong reproducibility among IHC laboratories using the same automation and reagents prepared per current Good Manufacturing Practices. However, when comparing different commercial vendors (using different reagents), the data reveal up to 100-fold differences in analytic sensitivity. For proficiency testing purposes, quantitative assessment using analytic response curves was superior to subjective interpretation of limits of detection. Conclusions.-Assessment of IHC laboratory performance by quantitative measurement of analytic response curves is a powerful, objective tool for identifying outlier IHC laboratories. It uniquely evaluates immunostain performance across a range of defined analyte concentrations.
引用
收藏
页码:851 / 862
页数:12
相关论文
共 32 条
[1]  
[Anonymous], CAP TODAY
[2]   Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer [J].
Asioli, Sofia ;
Maletta, Francesca ;
di Cantogno, Ludovica Verdun ;
Satolli, Maria A. ;
Schena, Marina ;
Pecchioni, Carla ;
Botta, Cristina ;
Chiusa, Luigi ;
Molinaro, Luca ;
Conti, Luca ;
Viale, Giuseppe ;
Ingravallo, Giuseppe ;
Maiorano, Eugenio ;
Sapino, Anna .
HUMAN PATHOLOGY, 2012, 43 (11) :2070-2079
[3]   Comparison of Anti-Estrogen Receptor Antibodies SP1, 6F11, and 1D5 in Breast Cancer [J].
Bogina, G. ;
Zamboni, G. ;
Sapino, A. ;
Bortesi, L. ;
Marconi, M. ;
Lunardi, G. ;
Coati, F. ;
Massocco, A. ;
Molinaro, L. ;
Pegoraro, C. ;
Venturini, M. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (05) :697-702
[4]   A Comparison of Estrogen Receptor SP1 and 1D5 Monoclonal Antibodies in Routine Clinical Use Reveals Similar Staining Results [J].
Brock, Jane E. ;
Hornick, Jason L. ;
Richardson, Andrea L. ;
Dillon, Deborah A. ;
Lester, Susan C. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (03) :396-401
[5]   Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival [J].
Cheang, Maggie C. U. ;
Treaba, Diana O. ;
Speers, Caroline H. ;
Olivotto, Ivo A. ;
Bajdik, Chris D. ;
Chia, Stephen K. ;
Goldstein, Lynn C. ;
Gelmon, Karen A. ;
Huntsman, David ;
Gilks, C. Blake ;
Nielsen, Torsten O. ;
Gown, Allen M. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) :5637-5644
[6]   Comparison of four immunohistochemical tests and FISH for measuring Her2 expression in gastric carcinomas [J].
Cho, Eun Yoon ;
Srivastava, Amitabh ;
Park, Kyeongmee ;
Kim, Jiyun ;
Lee, Min Hyeong ;
Do, Ingu ;
Lee, Jeeyun ;
Kim, Kyoung-Mee ;
Sohn, Tae Sung ;
Kang, Won Ki ;
Kim, Sung .
PATHOLOGY, 2012, 44 (03) :216-220
[7]   Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach [J].
Dekker, Tim J. A. ;
Ter Borg, Susan ;
Hooijer, Gerrit K. J. ;
Meijer, Sybren L. ;
Wesseling, Jelle ;
Boers, James E. ;
Schuuring, Ed ;
Bart, Jos ;
van Gorp, Joost ;
Mesker, Wilma E. ;
Kroep, Judith R. ;
Smit, Vincent T. H. B. M. ;
van de Vijver, Marc J. .
BREAST CANCER RESEARCH, 2012, 14 (03)
[8]   Development of new rabbit monoclonal antibody to estrogen receptor - Immunohistochemical assessment on formalin-fixed, paraffin-embedded tissue sections [J].
Huang, ZD ;
Zhu, WM ;
Szekeres, G ;
Xia, HY .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2005, 13 (01) :91-95
[9]   Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort [J].
Kornaga, Elizabeth N. ;
Klimowicz, Alexander C. ;
Guggisberg, Natalia ;
Ogilvie, Travis ;
Morris, Don G. ;
Webster, Marc ;
Magliocco, Anthony M. .
MODERN PATHOLOGY, 2016, 29 (12) :1492-1500
[10]   A systematic comparison of three commercial estrogen receptor assays in a single clinical outcome breast cancer cohort [J].
Kornaga, Elizabeth N. ;
Klimowicz, Alexander C. ;
Guggisberg, Natalia ;
Ogilvie, Travis ;
Morris, Don G. ;
Webster, Marc ;
Magliocco, Anthony M. .
MODERN PATHOLOGY, 2016, 29 (08) :799-809